|
|
|
|
RAMP is currently suspended
as a cost containment measure.
RAMP is the Rewarding Adherence to Medication Program. If a client is enrolled in RAMP, he/she will be able to receive 90 days of medications. This will reduce the number of times a client has to come in to pickup medications.
|
 |
|
- have been in the program for over 12 months or more
- are considered medically stable by their physician
- have picked-up medications on time for the past year and/or have an undetectable viral load
- have stable living arrangements and can be reached by phone
|
|
 |
|
- client must meet the criteria above and;
- a client's physician must sign the
RAMP authorization form for approval and client must also sign the Patient statement of understanding
|
|
 |
|
- Androderm
(Testosterone)
- Androgel
(Testosterone)
- Baraclude (Entecavir)
- Engerix-B (Hepatitis B)
- Epogen (Erythoropoietin)
- Flumadine (Rimantadine)
- Havrix (Hepatitis A)
- Hepsera (Adefovir)
- Levaquin (Levofloxacin)
- Lomotil (Diphenoxylate)
- Lyrica (Pregabalin)
- Lomotil (diphenoxylate)
- Marinol (Dronabinol)
- Neupogen (Filgrastim)
- Oxadrim (Oxandrolone)
- Pegasyz (Peginterferon Alfa)(2A)
- Peg-Intron (Peginterferon Alfa)(2B)
- Pneumovax (Pneumococcal)
- Pocrit (Epoetin Alfa)
- Relenza (Zanamivir)
- Ribasphere (Ribavirin)
- Symmentrel (Amantadine)
- Tamiflu (Oseltamivir)
- Twinrix (Hepatitis A/B)
|
|
|
| |
|
|
|
This page was last modified on: 08/10/2010 12:14:08
